Soliton Inc
NASDAQ:SOLY
Soliton Inc
Accrued Liabilities
Soliton Inc
Accrued Liabilities Peer Comparison
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Soliton Inc
NASDAQ:SOLY
|
Accrued Liabilities
$1.8m
|
CAGR 3-Years
16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Boston Scientific Corp
NYSE:BSX
|
Accrued Liabilities
$2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
5%
|
|
Stryker Corp
NYSE:SYK
|
Accrued Liabilities
$2.9B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
Abbott Laboratories
NYSE:ABT
|
Accrued Liabilities
$6.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Accrued Liabilities
$691.4m
|
CAGR 3-Years
21%
|
CAGR 5-Years
19%
|
CAGR 10-Years
15%
|
See Also
What is Soliton Inc's Accrued Liabilities?
Accrued Liabilities
1.8m
USD
Based on the financial report for Dec 31, 2020, Soliton Inc's Accrued Liabilities amounts to 1.8m USD.
What is Soliton Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 3Y
16%
Over the last year, the Accrued Liabilities growth was 20%. The average annual Accrued Liabilities growth rates for Soliton Inc have been 16% over the past three years .